Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and S-1 in Advanced Biliary Tract Cancer
NCT02146703Phase 2Completed
- Sponsor
- Hallym University Medical Center
- Start
- Aug 2005
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, tegafur in biliary tract cancer (BTC), sponsored by Hallym University Medical Center. Started Aug 2005; status: completed.
02
Drugs
gemcitabinetegafur
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT02146703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02146703.